NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-025-2022-0-CN-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF CN National Stage 202380034151.6 Pending
NEI E-015-2019-0-HK-01 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE HK CN 42024098024.3 Pending
NIDCR E-129-2021-0-HK-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction HK EP 62024097935.6 Pending
NCI E-237-2017-2-JP-02 T CELL RECEPTORS RECOGNIZING MUTATED P53 JP DIV 2024-178808 Issued
NIDDK E-067-2022-1-EP-01 A3 ADENOSINE RECEPTOR POSITIVE ALLOSTERIC MODULATORS EP National Stage 23718513.7 Pending
NIAID E-297-2016-2-JP-01 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES JP DIV 2024-178707 Pending
NCI E-027-2025-0-US-01 ANTIANGIOGENIC THERAPY IN COMBINATION WITH IMMUNOTOXIN AND ANTI-CD40 TO IMPROVE SURVIVAL IN BRAIN CANCER AND OTHER NEOPLASMS US 63/706,247 Expired
NHGRI E-222-2024-0-US-01 ADENO ASSOCIATED VIRAL (AAV) VECTORS FOR TREATMENT OF PROPIONIC ACIDEMIA (PA) CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA (PCCB) US 63/706,441 Expired
NCI E-239-2017-0-CN-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CN DIV 202411410030.X Pending
NIAID E-047-2022-0-CN-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses CN National Stage 202380033468.8 Pending
NIAID E-159-2024-0-US-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3
EXPRESSING AVIAN INFLUENZA VIRUS PROTEINS AND USE THEREOF 		US 63/705,659 Expired
NCI E-186-2025-0-US-01 AUTOPHAGY INHIBITOR THAT TARGETS THE ATG14L-BECLIN1 PROTEIN-PROTEIN INTERACTION US 63/705,241 Expired
NIAID E-090-2021-0-US-02 Bispecific Antibodies To Ebola Virus Glycoprotein And Their Use US National Stage 18/855,271 Pending
NHLBI E-036-2022-0-US-02 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS US National Stage 18/854,623 Pending
NIAAA E-172-2024-0-US-01 COMPOSITIONS AND METHODS FOR TREATING FIBROTIC AND INFLAMMATORY DISEASES US 63/704,345 Expired
NIAID E-137-2018-2-BR-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response BR DIV BR1220240208121 Pending
NCI E-067-2017-0-JP-02 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES JP DIV 2024-174698 Issued
NHLBI E-052-2022-0-US-02 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES US National Stage 18/854,462 Pending
NHLBI E-036-2022-0-JP-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS JP National Stage 2024-559137 Abandoned
NHLBI E-052-2022-0-JP-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES JP National Stage 2024-559257 Abandoned
NIAID E-060-2022-0-US-02 BETA GLOBIN MIMETIC PEPTIDES AND THEIR USE US National Stage 18/854,503 Pending
NIAID E-135-2010-0-US-03 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US CON 18/907,283 Abandoned
NIAID E-047-2024-0-PC-01 GENERATION OF ANTIGEN-SPECIFIC T AND B CELLS USING ENGINEERED COMMENSALS PCT PCT PCT/US2024/050039 Pending
NCI E-225-2024-0-PC-01 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES PCT PCT PCT/US2024/049800 Pending
NIDCR E-170-2024-0-US-01 SYSTEM FOR QUANTIFICATION OF HUMAN TEMPOROMANDIBULAR JOINT MECHANICS AND ORAL FUNCTION US 63/702,999 Expired
NCI E-235-2024-0-US-01 PATH2SPACE: AN AI APPROACH FOR CANCER BIOMARKER DISCOVERY VIA HISTOPATHOLOGY INFERRED SPATIAL TRANSCRIPTOMICS US 63/703,060 Expired
NCI E-166-2023-0-US-02 CANCER VACCINE AND METHOD OF USE THEREOF US 63/702,726 Expired
NHLBI E-090-2020-1-PC-01 NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE PCT PCT PCT/US2024/049658 Pending
NIAAA E-189-2021-0-EP-01 CANNABINOID RECEPTOR MODULATING COMPOUNDS EP National Stage 23719936.9 Pending
NIBIB E-054-2018-0-MO-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER MO CN J/008699 Issued
NEI E-155-2023-0-PC-01 BIOREACTOR SYSTEM PCT PCT PCT/US2024/049060 Pending
NCI E-231-2023-0-PC-01 COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELL-BASED VACCINES WITH ENHANCED EFFICACY PCT PCT PCT/US2024/049057 Pending
NINDS E-181-2023-0-PC-01 BRINCIDOFOVIR FOR TREATMENT OF MULTIPLE SCLEROSIS PCT PCT PCT/US2024/049002 Pending
NCATS E-042-2022-0-US-02 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS US National Stage 18/851,859 Pending
NIAID E-079-2022-0-US-02 BASE-COVERED HIV-1 ENVELOPE ECTODOMAINS AND THEIR USE US National Stage 18/852,276 Pending
NCATS E-042-2022-0-CN-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS CN National Stage 202380031329.1 Pending
NIAID E-137-2018-2-KR-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response KR DIV 10-2024-7032485 Pending
NIAID E-067-2016-3-US-01 METHOD OF VACCINATION WITH AN ATTENUATED RSV VACCINE FORMULATION US CON 18/898,953 Abandoned
NHLBI E-160-2023-0-PC-01 ANALOGUES OF N-LACTOYL-PHENYLALANINE, METHODS OF SYNTHESIS, AND METHODS OF USE PCT PCT PCT/US2024/048617 Pending
NCATS E-042-2022-0-CA-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS CA National Stage 3246976 Pending
NHLBI E-052-2022-0-CA-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES CA National Stage 3246953 Pending
NHLBI E-052-2022-0-IL-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES IL National Stage 315942 Pending
NIDCD E-220-2024-1-US-01 USING ARTIFICIAL INTELLIGENCE ALGORITHMS FOR DATA MODELING OF FUNCTIONAL HUMAN BRAIN ACTIVITY VIA FUNCTIONAL MAGNETIC RESONANCE IMAGING US 63/698,852 Expired
NICHD E-068-2023-0-US-01 NON-PARAMETRIC DIFFUSION TENSOR DISTRIBUTION MAGNETIC RESONANCE IMAGING US 63/698,918 Expired
NLM E-107-2010-2-US-43 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 18/894,673 Abandoned
NIDDK E-067-2022-1-US-01 A3 ADENOSINE RECEPTOR POSITIVE ALLOSTERIC MODULATORS US National Stage 18/850,144 Pending
NHLBI E-036-2022-0-IL-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS IL National Stage 315863 Pending
NIAID E-080-2022-0-CA-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE CA National Stage 3246703 Pending
NIAID E-073-2022-0-US-02 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US National Stage 18/849,734 Pending
NHLBI E-036-2022-0-CA-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS CA National Stage 3246616 Pending